Gali Health, a San Francisco, CA-based health tech company, raised over $2m in seed funding.
The round was led by Felicis Ventures with participation from Civilization Ventures and Bold Capital Partners, as well as angel investors Mostafa Ronaghi and Robert Nelsen.
The company intends to use the funds to accelerate the development and precision medicine-focused R&D efforts.
Gali Health advances precision medicine by crowdsourcing personal health data and medically-validated insights, applying AI to process them and providing personalized informational support on the medical, lifestyle and psychological aspects of living with chronic disease. The mobile personal health assistant named Gali leverages individual health information and collective intelligence to allow people with chronic conditions to proactively manage their health.
The assistant is now available to a broader initial group of users who live with inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis.
The company plans to release the Gali intelligent health assistant to the general public in the fall of 2019.